Oncology Institute stock soared more than 1,100% this year. The cancer care provider has produced solid revenue growth. However, the company continues to operate at a loss. 10 stocks we like better ...

Page 2: NVIDIA DGX Spark Review: Exploring Playbooks, Performance, And Our Conclusions NVIDIA DGX Spark - $3,999 MSRP NVIDIA's diminutive DGX Spark development companion moves away from the robotics ...

The small-but-mighty Spark can handle sophisticated AI models and still fit on your desk. The small-but-mighty Spark can handle sophisticated AI models and still fit on your desk. is a London-based ...

Nvidia Corporation maintains its AI hardware dominance, reinforced by a confirmed $2B investment in Elon Musk’s xAI and U.S. approval for UAE chip exports. The xAI partnership secures future demand ...

Among the laggards, the T-Rex 2X Inverse Nvidia Daily Target ETF (BATS:NVDQ) and the T-Rex 2X Inverse Tesla Daily Target ETF (BATS:TSLZ) stand out for their steep declines. Both funds seek to deliver ...

Tech giant Nvidia is the world’s leading artificial-intelligence chipmaker, but the company’s success has also put it in the crossfire of trade tensions. The Santa Clara, California-based company, ...

The National Highway Traffic Safety Administration said Thursday that it would investigate how Tesla’s semi-autonomous driving software handles railroad crossings as part of a wide-ranging ...

Musk shared a new video of the Tesla robot performing Kung Fu drills with its trainer, writing on X, "Tesla Optimus learning Kung Fu." The footage shows Optimus greeting its human instructor before ...

Elon Musk's electric vehicle company Tesla is once again being investigated by federal regulators. On Thursday, the U.S. National Highway Traffic Safety Administration (NHTSA) announced that it was ...

Since OpenAI's ChatGPT sparked the global AI boom in late 2022, the "Magnificent Seven"—Nvidia, Microsoft, Apple, Google, Amazon, Meta, and Tesla—have gained significant attention. Meanwhile, new AI ...

Tesla has been hit with an enforcement action by California’s Department of Insurance (CDI) for routinely denying or delaying customer claims despite years of warnings from the state regulator, ...